Literature DB >> 34255206

Multicontrast MRI-based radiomics for the prediction of pathological complete response to neoadjuvant chemotherapy in patients with early triple negative breast cancer.

Angeline Nemeth1, Pierre Chaudet2, Benjamin Leporq3,4, Pierre-Etienne Heudel5, Fanny Barabas2, Olivier Tredan5, Isabelle Treilleux6, Agnès Coulon2, Frank Pilleul1,2, Olivier Beuf1.   

Abstract

INTRODUCTION: To assess pre-therapeutic MRI-based radiomic analysis to predict the pathological complete response to neoadjuvant chemotherapy (NAC) in women with early triple negative breast cancer (TN).
MATERIALS AND METHODS: This monocentric retrospective study included 75 TN female patients with MRI (T1-weighted, T2-weighted, diffusion-weighted and dynamic contrast enhancement images) performed before NAC. For each patient, the tumor(s) and the parenchyma were independently segmented and analyzed with radiomic analysis to extract shape, size, and texture features. Several sets of features were realized based on the 4 different sequence images. Performances of 4 classifiers (random forest, multilayer perceptron, support vector machine (SVM) with linear or quadratic kernel) were compared based on pathological complete response (defined on the excised tissues), on 100 draws with 75% as training set and 25% as test.
RESULTS: The combination of features extracted from different MR images improved the classifier performance (more precisely, the features from T1W, T2W and DWI). The SVM with quadratic kernel showed the best performance with a mean AUC of 0.83, a sensitivity of 0.85 and a specificity of 0.75 in the test set.
CONCLUSION: MRI-based radiomics may be relevant to predict NAC response in TN cancer. Our results promote the use of multi-contrast MRI sources for radiomics, providing enrich source of information to enhance model generalization.
© 2021. European Society for Magnetic Resonance in Medicine and Biology (ESMRMB).

Entities:  

Keywords:  Breast cancer; Multi-contrast MRI; Radiomics; Triple negative breast cancer

Year:  2021        PMID: 34255206     DOI: 10.1007/s10334-021-00941-0

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  2 in total

1.  Prediction of cervical cancer recurrence using textural features extracted from 18F-FDG PET images acquired with different scanners.

Authors:  Sylvain Reuzé; Fanny Orlhac; Cyrus Chargari; Christophe Nioche; Elaine Limkin; François Riet; Alexandre Escande; Christine Haie-Meder; Laurent Dercle; Sébastien Gouy; Irène Buvat; Eric Deutsch; Charlotte Robert
Journal:  Oncotarget       Date:  2017-06-27

2.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.

Authors:  J Ferlay; M Colombet; I Soerjomataram; C Mathers; D M Parkin; M Piñeros; A Znaor; F Bray
Journal:  Int J Cancer       Date:  2018-12-06       Impact factor: 7.396

  2 in total
  1 in total

Review 1.  Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine.

Authors:  Françoise Derouane; Cédric van Marcke; Martine Berlière; Amandine Gerday; Latifa Fellah; Isabelle Leconte; Mieke R Van Bockstal; Christine Galant; Cyril Corbet; Francois P Duhoux
Journal:  Cancers (Basel)       Date:  2022-08-11       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.